BAVARIAN NORDIC A/S (BV3.DE) Stock Price, Forecast & Analysis
Europe • Frankfurt Stock Exchange • FRA:BV3 • DK0015998017
BV3.DE Key Statistics, Chart & Performance
The current stock price of BV3.DE is 26.26 EUR. In the past month the price increased by 7.05%.
BV3.DE Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to BV3.DE.
BV3.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to BV3.DE. BV3.DE is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
BV3.DE Financial Highlights
Over the last trailing twelve months BV3.DE reported a non-GAAP Earnings per Share(EPS) of 2.27. The EPS increased by 39.44% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 35.5% | ||
| ROA | 16.13% | ||
| ROE | 18.58% | ||
| Debt/Equity | 0.01 |
BV3.DE Forecast & Estimates
9 analysts have analysed BV3.DE and the average price target is 34.14 EUR. This implies a price increase of 30% is expected in the next year compared to the current price of 26.26.
For the next year, analysts expect an EPS growth of 54.87% and a revenue growth 9.45% for BV3.DE
BV3.DE Ownership
BV3.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ARGX | ARGENX SE | 28.13 | 44.408B | ||
| 1AE | ARGENX SE | 28.28 | 44.383B | ||
| 22UA | BIONTECH SE-ADR | N/A | 22.29B | ||
| 2X1 | ABIVAX SA | N/A | 7.491B | ||
| ABVX | ABIVAX SA | N/A | 7.46B | ||
| GXE | GALAPAGOS NV | N/A | 1.918B | ||
| GLPG | GALAPAGOS NV | N/A | 1.915B | ||
| 6IV | INVENTIVA SA | N/A | 1.015B | ||
| IVA | INVENTIVA SA | N/A | 973.063M | ||
| NANO | NANOBIOTIX | N/A | 880.66M |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About BV3.DE
Company Profile
Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in research and development innovations, production and commercialization of life-saving vaccines based on viral vectors for the delivery of antigens targeting infectious diseases. Bavarian Nordic A/S offers travel health products including cholera, rabies, tick-borne encephalitis and typhoid vaccines, as well as vaccines sold and distributed in selected markets on behalf of third parties. The firm deals with vaccines aimed at improving public health and preparedness. Bavarian Nordic A/S focuses on vaccine solutions that help address the threat of infectious diseases. The firm operates worldwide.
Company Info
BAVARIAN NORDIC A/S
Philip Heymans Alle 3
Hellerup DK
Employees: 1605
Phone: 4533268383
BAVARIAN NORDIC A/S / BV3.DE FAQ
Can you describe the business of BAVARIAN NORDIC A/S?
Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in research and development innovations, production and commercialization of life-saving vaccines based on viral vectors for the delivery of antigens targeting infectious diseases. Bavarian Nordic A/S offers travel health products including cholera, rabies, tick-borne encephalitis and typhoid vaccines, as well as vaccines sold and distributed in selected markets on behalf of third parties. The firm deals with vaccines aimed at improving public health and preparedness. Bavarian Nordic A/S focuses on vaccine solutions that help address the threat of infectious diseases. The firm operates worldwide.
What is the stock price of BAVARIAN NORDIC A/S today?
The current stock price of BV3.DE is 26.26 EUR. The price increased by 2.02% in the last trading session.
Does BAVARIAN NORDIC A/S pay dividends?
BV3.DE does not pay a dividend.
What is the ChartMill rating of BAVARIAN NORDIC A/S stock?
BV3.DE has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What is the analyst forecast for BV3.DE stock?
9 analysts have analysed BV3.DE and the average price target is 34.14 EUR. This implies a price increase of 30% is expected in the next year compared to the current price of 26.26.
Can you provide the sector and industry classification for BAVARIAN NORDIC A/S?
BAVARIAN NORDIC A/S (BV3.DE) operates in the Health Care sector and the Biotechnology industry.
What is the employee count for BV3 stock?
BAVARIAN NORDIC A/S (BV3.DE) currently has 1605 employees.